US Patent 11926661 Human antibodies to artemin and methods of use thereof
Patent 11926661 was granted and assigned to Regeneron Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+214 characters)
US Patent 11926661 Human antibodies to artemin and methods of use thereof
Article
Patent abstract
The present disclosure provides antibodies and antigen-binding fragments thereof that bind to human artemin. Methods for using anti-artemin antibodies and antigen-binding fragments are also provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew J. Murphy0
Lynn MacDonald0
Susan D. Croll0
Date of Patent
March 12, 2024
0Patent Application Number
177243810
Date Filed
April 19, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11926661 Human antibodies to artemin and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.